Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

HeartFlow offers a groundbreaking, non-invasive cardiac test that delivers detailed visualizations of individual coronary arteries, allowing doctors to develop more tailored treatment strategies for their patients. The process begins when a patient has a standard coronary computed tomography scan performed at a medical facility. Following this scan, the CT images are securely sent to our cloud-based system. Utilizing cutting-edge algorithms powered by artificial intelligence, we create a customized digital representation of the patient's coronary arteries. Our skilled analysts then review this model, making necessary adjustments to ensure accuracy. After finalizing the patient-specific model, the HeartFlow pathway employs physiological principles and computational fluid dynamics to analyze blood flow and compute FFRCT values throughout the model. We adhere to strict and well-established protocols throughout this entire process, ensuring uniform processing for every individual patient, which ultimately enhances the quality of care provided. This innovative approach not only improves diagnostic precision but also empowers healthcare providers to make informed decisions for optimal patient outcomes.

Description

Introducing a versatile API designed to seamlessly integrate with your diabetes management system, offering tailored therapeutic education and enhanced insights into blood glucose level fluctuations. This solution enables real-time risk predictions, fostering greater personalization and improved system regulation, while adeptly managing complex living scenarios characterized by rapid glucose variations. With advancements in telemedicine and retrospective analysis, patients receive robust decision-support tools. Currently, Hillo is developing the next iterations of its AI technology, which includes a therapeutic recommendation system aimed at preventing hypoglycemia and hyperglycemia, anticipated to achieve CE mark class IIB by 2020. Additionally, a new generation of the artificial pancreas is projected for release in 2021, addressing key limitations of existing systems through ultra-personalization driven by machine learning. This innovative approach marks the introduction of the first self-learning artificial intelligence capable of predicting blood glucose levels, aiming to secure a CE mark as a medical device, thereby transforming diabetes management for users. In essence, Hillo's advancements could significantly enhance the quality of life for individuals managing diabetes.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

HeartFlow

Founded

2010

Country

United States

Website

www.heartflow.com

Vendor Details

Company Name

Hillo

Country

France

Website

www.hillo.ai/

Product Features

Medical Imaging

Automated Routing
Comparison View
Compliance Management
Data Import / Export
Diagnostic Reporting
Image Analytics
Treatment Planning
Workflow Management

Product Features

Alternatives

Alternatives

Medis Suite XA Reviews

Medis Suite XA

Medis Medical Imaging Systems
Altis Labs Nota Reviews

Altis Labs Nota

Altis Labs